The recent instability in global chains have highlighted the necessity of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes regions to considerable vulnerabilities, including shipping delays, expense fluctuations, and even geopolitical risks. Transitioning towards domestic sourcing of Ivermectin offers a mu